Beskæftigelsesudvalget 2023-24
BEU Alm.del Bilag 195
Offentligt
2885000_0001.png
Exposure to workplace sexual harassment and risk of cardiometabolic diseases: a
prospective cohort study of 88,904 Swedish men and women
Prakash KC, Madsen I, Rugulies R, Xu T, Westerlund H, Nyberg A, Kivimäki M, Magnusson Hanson LL*
*Corresponding author: Linda L Magnusson Hanson, Stress Research Institute, Department of Psychology
Stockholm University, 106 91 Stockholm, Sweden; Email address:
[email protected]
Supplementary Table 1:
Person-time years and rates per 1000 person-years among total population and
stratified by exposure status
By exposure to sexual harassment
p-
value*
Unexposed
Unexposed
Person -
Rates
Person -
Rates
Person -
Rates
years
(95% CI)
years
(95% CI)
years
(95% CI)
CVD
989512
4.3(4.1-
943796
4.4(4.2-
45722
2.4(2.0-
0.79
4.4)
4.5)
2.9)
type 2 diabetes
997013
3.6(3.5-
951215
3.7(3.6-
45799
2.8(2.4-
0.81
3.8)
3.8)
3.3)
CHD
996192
2.8(2.7-
950273
2.9(2.8-
45919
1.4(1.1-
0.19
2.9)
3.0)
1.8)
Cerebrovascular
1001289
1.9(1.85-
955330
2.0(1.9-
45958
1.3(1.0-
0.54
disease
2.02)
2.1)
1.6)
MI
1001306
1.8(1.7-
955251
1.8(1.7-
46054
0.9(0.7-
0.08
1.9)
1.9)
1.3)
Stroke
1003497
1.5(1.4-
957426
1.5(1.4-
46071
0.8(0.6-
0.78
1.6)
1.6)
1.11)
Note: CI, Confidence Interval; CVD,
cardiovascular disease; CHD, coronary heart disease; MI, myocardial
infarction;
*p-value for proportionality hazard test (p>0.05 indicates assumption was justified)
Supplementary Table 2:
Distribution of Cardiometabolic diseases among employees in SWES 1995-2015
according to exposure to workplace sexual harassment
Diseases
CHD
No
Yes
Cerebrovascular disease
No
Yes
MI
No
Yes
Stroke
No
Yes
Total
(N, 88904)
n
(%)
86120
2784
86969
1935
87128
1776
97
3
98
2
98
2
Unexposed
(n, 84604)
n
%
81886
2718
82727
1877
82871
1733
97
3
98
2
98
2
Exposed
(n,4300)
n
%
4234
66
4242
58
4257
43
98
2
< 0.0001
99
1
<0.0001
99
1
<0.0001
p-value*
<0.0001
Diseases
All
87416
98
83153
98 4263 99
1488
2
1451
2
37
1
Note: SD, Standard Deviation; CVD,
cardiovascular disease; CHD, coronary heart disease; MI, myocardial
infarction;
*p-value for hypothesis testing that one group is different from other based on chi-square test
1
BEU, Alm.del - 2023-24 - Bilag 195: Orientering om nye forskningsresultater om sammenhæng mellem seksuel chikane på arbejdspladsen og risiko for hjertekarsygdom og/eller type 2-diabetes, fra beskæftigelsesministeren
2885000_0002.png
Supplementary Figure 1:
Results from Cox regression analyses on workplace sexual harassment presented
as hazard ratios (HR) and 95% confidence intervals (CI) with and without adjustment for covariates (for CHD,
cerebrovascular disease, MI, and stroke)
2
BEU, Alm.del - 2023-24 - Bilag 195: Orientering om nye forskningsresultater om sammenhæng mellem seksuel chikane på arbejdspladsen og risiko for hjertekarsygdom og/eller type 2-diabetes, fra beskæftigelsesministeren
2885000_0003.png
Supplementary Figure 2:
Results from Cox regression analyses on workplace sexual harassment stratified
by sex, presented as hazard ratios (HR) and 95% confidence intervals (CI) with and without adjustment for
covariates (CHD, cerebrovascular disease, MI, and stroke)
3
BEU, Alm.del - 2023-24 - Bilag 195: Orientering om nye forskningsresultater om sammenhæng mellem seksuel chikane på arbejdspladsen og risiko for hjertekarsygdom og/eller type 2-diabetes, fra beskæftigelsesministeren
2885000_0004.png
Supplementary Figure 3:
Results from Cox regression analyses on workplace sexual harassment from
superiors/ fellow workers or others, presented as hazard ratios (HR) and 95% confidence intervals (CI) with
and without adjustment for covariates (CHD, cerebrovascular disease, MI, and stroke)
4
BEU, Alm.del - 2023-24 - Bilag 195: Orientering om nye forskningsresultater om sammenhæng mellem seksuel chikane på arbejdspladsen og risiko for hjertekarsygdom og/eller type 2-diabetes, fra beskæftigelsesministeren
2885000_0005.png
Supplementary Table 3:
Results from Cox regression analyses on frequency of workplace sexual harassment
presented as hazard ratios (HR) and 95% confidence intervals with and without adjustment for covariates
Model I
b
CVD
a
HR
(95% CI)
Frequency of workplace sexual
harassment
Every day to at least 2
days/month
Sometime during last 3 months
Once or twice during last 12
months
Not at all during last 12 months
2.65 (1.19-5.91)
2.32 (0.58-9.27)
1.22 (1.01-1.49)
Referent
2.47 (1.22-5.02)
2.19 (0.60-8.00)
1.22 (1.00-1.49)
Referent
2.32 (1.04-5.17)
2.15 (0.54-8.62)
1.20 (0.98-1.47)
Referent
Model II
c
HR
(95% CI)
Model IV
d
HR
(95% CI)
Type-2-Diabetes
a
Frequency of workplace sexual
harassment
Every day to at least 2
days/month
Sometime during last 3 months
Once or twice during last 12
months
Not at all during last 12 months
1.69 (0.85-4.52)
7.18 (2.23-15.98)
1.44 (1.20-1.74)
Referent
1.62 (0.60-4.38)
6.78 (3.04-15.12)
1.41 (1.17-1.70)
Referent
1.53 (0.57-4.09)
6.65 (2.98-14.83)
1.39 (1.15-1.67)
Referent
Note: HR, Hazard Ratio; CI, Confidence Interval; N, Number with valid data; C, Number of cases;
a
Cardiovascular disease and type-2-diabetes based on inpatient register, outpatient register and death register;
b
Adjusted for sex;
c
Model II+birth country, family situation, education, and income at baseline;
d
Model III+
job demands, job control, social support, and physical strain at work at baseline
5